A New Korean Nomenclature for Steatotic Liver Disease
The Korean Journal of Gastroenterology · 2024
DOI: 10.4166/kjg.2024.066 ↗Kurz gefasst
Editorial in der Zeitschrift The Korean Journal of Gastroenterology, 2024. Verfasst von Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL). Hauptthemen laut MEDLINE: Fatty Liver, Terminology as Topic. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL). Korean J Gastroenterol 2024;84:1-2. https://doi.org/10.4166/kjg.2024.066
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL) (2024). A New Korean Nomenclature for Steatotic Liver Disease. The Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2024.066
Vancouver
Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL). A New Korean Nomenclature for Steatotic Liver Disease. The Korean Journal of Gastroenterology. 2024. doi:10.4166/kjg.2024.066
BibTeX
@article{NonalcoholicFattyLiverDiseaseNAFLDNomenclatureRevisionConsensusTaskForceonbehalfoftheKoreanAssociationfortheStudyoftheLiverKASL2024,
author = {Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL), Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)},
title = {A New Korean Nomenclature for Steatotic Liver Disease},
journal = {The Korean Journal of Gastroenterology},
year = {2024},
doi = {10.4166/kjg.2024.066}
}
EUVIMED